Description

Chemical Properties

Description

Survodutide (Slupp 332) is a dual GLP-1 and glucagon receptor agonist under investigation for its role in obesity and metabolic disorder research. By promoting feelings of fullness, enhancing lipid oxidation, and boosting energy expenditure, it offers a multi-mechanistic approach to studying weight management. Preliminary research highlights its potential as a valuable tool for exploring next-generation metabolic therapies.